Advertisement
Screener

Vir Biotechnology, Inc. (VIR) Other

Vir Biotechnology, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-02-23: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market.
  • 2025-02-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market.
  • 2024-02-26: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market.
  • 2023-02-28: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market.
FiledFormItemAs filed
2026-02-2310-KStock registered under Section 12(b)Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market
2025-02-2710-KStock registered under Section 12(b)Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market
2024-02-2610-KStock registered under Section 12(b)Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market
2023-02-2810-KStock registered under Section 12(b)Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market
2022-02-2810-KStock registered under Section 12(b)Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market
2021-02-2510-KStock registered under Section 12(b)Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market
2020-11-1010-QEmerging growth companyYes
2020-08-1110-QEmerging growth companyYes
2020-05-1210-QEmerging growth companyYes
2020-03-2610-KStock registered under Section 12(b)Common Stock, $0.0001 par value · VIR · Nasdaq Global Select Market
2020-03-2610-KEmerging growth companyYes
2020-03-2610-KWell-known seasoned issuerNo
2019-11-1910-QEmerging growth companyYes
2019-11-1910-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Vericel Corp (VCEL)United States$2.011B93.97
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40